Masimo secured significant, highly publicized legal victories in its multi-year patent disputes against Apple, most notably when a federal jury ordered Apple to pay hundreds of millions of dollars for infringing on vital pulse-oximetry and blood-oxygen monitoring patent rights. Furthermore, Masimo's successful complaints before the U.S. International Trade Commission previously resulted in strict import restrictions on certain generations of infringing Apple Watch models, marking major legal milestones for the medical technology firm.